✦ LIBER ✦

Phase II Trial of Intraperitoneal Cisplatin and Mitoxantrone in Patients with Persistent Ovarian Cancer

✍ Scribed by A. Husain; P. Sabbatini; D. Spriggs; D. Fennelly; C. Aghajanian; R. Barakat; J. Curtin; E. Venkatraman; W. Hoskins; M. Markman

Book ID: 112247645
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 53 KB
Volume: 73
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.1998.5317

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I–II trial of intraperitoneal ci

A phase I–II trial of intraperitoneal cisplatin and α-lnterferon in patients with persistent epithelial ovarian cancer

✍ Jonathan S. Berek; Charles Welander; Julian C. Schink; Howard Grossberg; Frederi 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 771 KB

A phase I–II trial of intraperitoncal ci

A phase I–II trial of intraperitoncal cisplatin and a-interferon in patients with persistent epithelial ovarian cancer

✍ Js Berek; C Welander; JC Schink; H Grossberg; FJ Montz; J Zigelboim 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Phase II trial of intraperitoneal cispla

Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer

✍ Lisa M. Landrum; Johnny Hyde Jr.; Robert S. Mannel; D. Scott McMeekin; Kathleen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Intraperitoneal (ip) Cisplatin-Mitoxantr

Intraperitoneal (ip) Cisplatin-Mitoxantrone-Interferon-α2b in Ovarian Cancer Patients with Minimal Residual Disease

✍ G. Frasci; A. Tortoriello; G. Facchini; S. Conforti; A. Cardone; G. Persico; P. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 426 KB

Phase II trial of tamoxifen, etoposide,

Phase II trial of tamoxifen, etoposide, mitoxantrone, and cisplatin in patients with metastatic breast carcinoma

✍ Suzanne D. Conzen; Peter A. Kaufman; Christine Arvizu; Paul LeMarbre; L. Herbert 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 554 KB

## BACKGROUND. Based on previous data demonstrating a potentially synergistic interaction between tamoxifen and cisplatin in metastatic melanoma therapy, a Phase I1 study was performed to assess the activity of tamoxifen, etoposide, mitoxantrone, and cisplatin (TEMP) in patients with metastatic br

Phase II Trial of Combination Intraperit

Phase II Trial of Combination Intraperitoneal Cisplatin and 5-Fluorouracil in Previously Treated Patients with Advanced Ovarian Cancer: Long-Term Follow-up

✍ Robert J. Morgan Jr.; Patricia Braly; Lucille Leong; Stephen Shibata; Kim Margol 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 58 KB